
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7470670
[patent_doc_number] => 20040096855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Genes'
[patent_app_type] => new
[patent_app_number] => 10/444190
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23761
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20040096855.pdf
[firstpage_image] =>[orig_patent_app_number] => 10444190
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/444190 | Genes | May 22, 2003 | Abandoned |
Array
(
[id] => 220857
[patent_doc_number] => 07608403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-27
[patent_title] => 'Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell'
[patent_app_type] => utility
[patent_app_number] => 10/514771
[patent_app_country] => US
[patent_app_date] => 2003-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4240
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/608/07608403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514771 | Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell | May 19, 2003 | Issued |
Array
(
[id] => 6865124
[patent_doc_number] => 20030190650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Screening method'
[patent_app_type] => new
[patent_app_number] => 10/332130
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17085
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190650.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332130
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332130 | Screening method | May 18, 2003 | Abandoned |
Array
(
[id] => 5747800
[patent_doc_number] => 20060110731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Cancer-linked gene as target for chemotherapy'
[patent_app_type] => utility
[patent_app_number] => 10/514535
[patent_app_country] => US
[patent_app_date] => 2003-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13214
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110731.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514535
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514535 | Cancer-linked gene as target for chemotherapy | May 14, 2003 | Abandoned |
Array
(
[id] => 5743169
[patent_doc_number] => 20060088894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Prostate cancer biomarkers'
[patent_app_type] => utility
[patent_app_number] => 10/513649
[patent_app_country] => US
[patent_app_date] => 2003-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22146
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088894.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513649
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513649 | Prostate cancer biomarkers | May 8, 2003 | Abandoned |
Array
(
[id] => 7382198
[patent_doc_number] => 20040029157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Cell cycle control protein'
[patent_app_type] => new
[patent_app_number] => 10/429849
[patent_app_country] => US
[patent_app_date] => 2003-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7708
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029157.pdf
[firstpage_image] =>[orig_patent_app_number] => 10429849
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/429849 | Cell cycle control protein | May 5, 2003 | Abandoned |
Array
(
[id] => 7361671
[patent_doc_number] => 20040014659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/428164
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20784
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014659.pdf
[firstpage_image] =>[orig_patent_app_number] => 10428164
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/428164 | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | May 1, 2003 | Abandoned |
Array
(
[id] => 7362514
[patent_doc_number] => 20040005302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Encapsulated cells to elicit immune responses'
[patent_app_type] => new
[patent_app_number] => 10/428519
[patent_app_country] => US
[patent_app_date] => 2003-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15090
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10428519
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/428519 | Encapsulated cells to elicit immune responses | Apr 29, 2003 | Abandoned |
Array
(
[id] => 7429722
[patent_doc_number] => 20040001844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Lewis Y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/421198
[patent_app_country] => US
[patent_app_date] => 2003-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9843
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10421198
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/421198 | Lewis Y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof | Apr 21, 2003 | Abandoned |
Array
(
[id] => 6701587
[patent_doc_number] => 20030224467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'AIB1 as a prognostic marker and predictor of resistance to endocrine therapy'
[patent_app_type] => new
[patent_app_number] => 10/418027
[patent_app_country] => US
[patent_app_date] => 2003-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 37213
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224467.pdf
[firstpage_image] =>[orig_patent_app_number] => 10418027
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/418027 | AIB1 as a prognostic marker and predictor of resistance to endocrine therapy | Apr 16, 2003 | Abandoned |
Array
(
[id] => 7545580
[patent_doc_number] => 08053552
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => 'Neopeptides and methods useful for detection and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/511698
[patent_app_country] => US
[patent_app_date] => 2003-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 16866
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/053/08053552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511698
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511698 | Neopeptides and methods useful for detection and treatment of cancer | Apr 16, 2003 | Issued |
Array
(
[id] => 63392
[patent_doc_number] => 07759068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-20
[patent_title] => 'Use of substances for treating tumors'
[patent_app_type] => utility
[patent_app_number] => 10/511205
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5257
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/759/07759068.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511205
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511205 | Use of substances for treating tumors | Apr 14, 2003 | Issued |
Array
(
[id] => 7393217
[patent_doc_number] => 20040038259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Method of producing a temporally spaced subtracted (TSS) cDNA library and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/412987
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17668
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038259.pdf
[firstpage_image] =>[orig_patent_app_number] => 10412987
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/412987 | mda-9 protein | Apr 13, 2003 | Issued |
Array
(
[id] => 7039292
[patent_doc_number] => 20050158726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Compositons and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene'
[patent_app_type] => utility
[patent_app_number] => 10/511813
[patent_app_country] => US
[patent_app_date] => 2003-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13556
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158726.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511813
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511813 | Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene | Apr 11, 2003 | Issued |
Array
(
[id] => 6931130
[patent_doc_number] => 20050282165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Diagnosis of Carcinoma Using RAIG1 Polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/510507
[patent_app_country] => US
[patent_app_date] => 2003-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15528
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282165.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510507 | Diagnosis of Carcinoma Using RAIG1 Polypeptides | Apr 9, 2003 | Abandoned |
Array
(
[id] => 893991
[patent_doc_number] => 07341721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-11
[patent_title] => 'β2-microglobulin (β2m) and anti-β2m binding agents as anti-cancer therapeutics'
[patent_app_type] => utility
[patent_app_number] => 10/410798
[patent_app_country] => US
[patent_app_date] => 2003-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 13494
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/341/07341721.pdf
[firstpage_image] =>[orig_patent_app_number] => 10410798
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/410798 | β2-microglobulin (β2m) and anti-β2m binding agents as anti-cancer therapeutics | Apr 9, 2003 | Issued |
Array
(
[id] => 33987
[patent_doc_number] => 07786278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Modified CEA nucleic acid and expression vectors'
[patent_app_type] => utility
[patent_app_number] => 10/510677
[patent_app_country] => US
[patent_app_date] => 2003-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13646
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/786/07786278.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510677
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510677 | Modified CEA nucleic acid and expression vectors | Apr 8, 2003 | Issued |
Array
(
[id] => 7227945
[patent_doc_number] => 20050255468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Method for discrimination of metaplasias from neoplastic or preneoplastic lesions'
[patent_app_type] => utility
[patent_app_number] => 10/511108
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5321
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255468.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511108
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511108 | Method for discrimination of metaplasias from neoplastic or preneoplastic lesions | Apr 7, 2003 | Issued |
Array
(
[id] => 5230316
[patent_doc_number] => 20070292423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Method of Defining the Differentiation Grade of Tumor'
[patent_app_type] => utility
[patent_app_number] => 10/552178
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12907
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20070292423.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552178
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552178 | Method of Defining the Differentiation Grade of Tumor | Apr 7, 2003 | Abandoned |
Array
(
[id] => 6865162
[patent_doc_number] => 20030190688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Methods for detecting BCR-ABL signaling activity in tissues using phospho-specific antibodies'
[patent_app_type] => new
[patent_app_number] => 10/408486
[patent_app_country] => US
[patent_app_date] => 2003-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11151
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190688.pdf
[firstpage_image] =>[orig_patent_app_number] => 10408486
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/408486 | Methods for detecting BCR-ABL signaling activity in tissues using phospho-specific antibodies | Apr 6, 2003 | Abandoned |